dr. A.H. Oude Voshaar (Martijn)

Oude Voshaar, M., Terwee, C. B., Haverman, L., van der Kolk, B., Harkes, M., van Woerden, C. S., van Breda, F., Breukink, S., de Hoop, I., Vermeulen, H., de Graaf, E., Hazelet, J., van Leiden, B., Stienen, J., Hoekstra, M., Bart, H., van Bommel, H., Determann, D., Verburg, M., ... Beurskens, A. J. (2023). Development of a standard set of PROs and generic PROMs for Dutch medical specialist care: Recommendations from the Outcome-Based Healthcare Program Working Group Generic PROMs. Quality of life research, 32(6), 1595-1605. https://doi.org/10.1007/s11136-022-03328-3

van de Laar, C. J. , Janssen, C. A., Janssen, M. , Oude Voshaar, M. A. H., Maiwenn, J. AL. , & van de Laar, M. A. F. J. (2022). Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients. PLoS ONE, 17(1 January), Article e0261940. https://doi.org/10.1371/journal.pone.0261940

Shoop-Worrall, S. J. W. , Oude Voshaar, M. A. H., McDonagh, J. E. , van de Laar, M. A. F. J., Wulffraat, N., Thomson, W., Hyrich, K. L., & Verstappen, S. M. M. (2021). Common Functional Ability Score for Young People With Juvenile Idiopathic Arthritis. Arthritis Care and Research, 73(7), 947-954. https://doi.org/10.1002/acr.24204

Spijk-de Jonge, M. J. , Oude Voshaar, M. A. H., Renskers, L., Huis, A. M. P. , van de Laar, M. A. F. J., Hulscher, M. E. J. L., & van Riel, P. L. C. M. (2020). Two parallel short forms to measure disease- And treatment-associated knowledge in rheumatoid arthritis: Application of item response theory. Rheumatology advances in practice, 4(2), 1-8. https://doi.org/10.1093/rap/rkaa012

van de Laar, C. J. , Oude Voshaar, M. A. H., Fakhouri, W. K. H., Zaremba-Pechmann, L., De Leonardis, F., de la Torre, I. , & van de Laar, M. A. F. J. (2020). Cost-effectiveness of a JAK1/JAK2 inhibitor vs a biologic disease-modifying antirheumatic drug (Bdmard) in a treat-to-target strategy for rheumatoid arthritis. ClinicoEconomics and Outcomes Research, 12, 213-222. https://doi.org/10.2147/CEOR.S231558

Weiss, L. A. , Oude Voshaar, M. A. H. , Bohlmeijer, E. T. , & Westerhof, G. J. (2020). The long and winding road to happiness: A randomized controlled trial and cost-effectiveness analysis of a positive psychology intervention for lonely people with health problems and a low socio-economic status. Health and quality of life outcomes, 18(1), Article 162. https://doi.org/10.1186/s12955-020-01416-x

Janssen, C. A. , Oude Voshaar, M. A. H. , Vonkeman, H. E., Jansen, T. L. T. A., Janssen, M., Kok, M. R., Radovits, B., van Durme, C. , Baan, H. , & van de Laar, M. A. F. J. (2019). Anakinra for the treatment of acute gout flares: A randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial. Rheumatology, 58(8), 1344-1352. https://doi.org/10.1093/rheumatology/key402

van de Laar, C. J. , Oude Voshaar, M. A. H. , & Vonkeman, H. E. (2019). Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: Results from the DREAM registry. BMC Rheumatology, 3(1), Article 16. https://doi.org/10.1186/s41927-019-0064-9

Oude Voshaar, M. A. H. (2019). Stoppen met TNF-a-blokkers bij reumatoïde artritis? Nederlands tijdschrift voor geneeskunde, 163(14), Article D3414. https://www.ntvg.nl/artikelen/stoppen-met-tnf-blokkers-bij-reumatoide-artritis

Oude Voshaar, M. A. H., Das Gupta, Z., Bijlsma, J. W. J., Boonen, A., Chau, J., Courvoisier, D. S., Curtis, J. R., Ellis, B., Ernestam, S., Gossec, L., Hale, C., Hornjeff, J., Leung, K. Y. Y., Lidar, M., Mease, P., Michaud, K., Mody, G. M., Ndosi, M., Opava, C. H. , ... Vonkeman, H. E. (2019). International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group. Arthritis Care and Research, 71(12), 1556-1565. https://doi.org/10.1002/acr.23799